Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,057 | 5,189 | 4,595 | 3,885 | 4,024 |
| Receivables | 687 | 398 | 922 | 694 | 475 |
| Inventories | 3,426 | 2,661 | 2,602 | 1,747 | 1,683 |
| Other current assets | 120 | 140 | 137 | 138 | 144 |
| TOTAL | $9,477 | $8,594 | $8,912 | $6,804 | $6,732 |
| Non-Current Assets | |||||
| PPE Net | 118 | 122 | 128 | 136 | 134 |
| TOTAL | $118 | $122 | $128 | $136 | $134 |
| Total Assets | $9,595 | $8,716 | $9,040 | $6,940 | $6,866 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 132 | 389 | 477 | 112 | 333 |
| Accrued Expenses | N/A | N/A | N/A | 463 | N/A |
| Other current liabilities | 1,813 | 1,683 | 2,740 | 1,946 | 1,672 |
| TOTAL | $2,653 | $2,671 | $4,326 | $2,543 | $2,351 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | -1,789 | -1,215 | -596 | -283 | -196 |
| TOTAL | $1 | $4 | $7 | $11 | $16 |
| Total Liabilities | $2,654 | $2,675 | $4,333 | $2,554 | $2,367 |
| Shareholders' Equity | |||||
| Retained earnings | -34,794 | -34,504 | -34,841 | -33,074 | -32,191 |
| TOTAL | $5,152 | $4,826 | $4,111 | $4,103 | $4,303 |
| Total Liabilities And Equity | $7,806 | $7,501 | $8,444 | $6,657 | $6,670 |